Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Current Eye Research|April 6, 2019
Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic DermatitisJun Shoji, Yuichi Ohashi, Atsuki Fukushima, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 16, 2009
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitisNobuyuki Ebihara, Yuichi Ohashi, Eiichi Uchio, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 24, 2010
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitisYuichi Ohashi, Nobuyuki Ebihara, Hiroshi Fujishima, et al.The Journal of Allergy and Clinical Immunology|March 12, 2016
The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseasesHiroshi Fujishima, Naoko Okada, Kenji Matsumoto, et al.Allergology International : Official Journal of the Japanese Society of Allergology|February 25, 2012
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspensionNobuyuki Ebihara, Yuichi Ohashi, Hiroshi Fujishima, et al.Current Eye Research|October 28, 2005
Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcersMurat Dogru, Naoko Asano-Kato, Mari Tanaka, et al.The British Journal of Ophthalmology|April 4, 2014
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvementAtsuki Fukushima, Yuichi Ohashi, Nobuyuki Ebihara, et al.Nippon Ganka Gakkai Zasshi|July 9, 2011
[A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, et al.Japanese Journal of Ophthalmology|October 7, 2020
Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseasesDai Miyazaki, Daisuke Shimizu, Atsuki Fukushima, et al.Molecular Cell|September 9, 2017
Temperature-Sensitive Substrate and Product Binding Underlie Temperature-Compensated Phosphorylation in the ClockYuta Shinohara, Yohei M Koyama, Maki Ukai-Tadenuma, et al.Pageof 11